EXOSENS PROM (EXENS.PA)
EUR 17.09
(-0.77%)
EUR 17.09
(-0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | 50.46 Million | 47.48 Million | 42.65 Million | 44.11 Million |
| Net Income | 18.4 Million | 11.21 Million | -148.96 Million | -15.82 Million |
| Depreciation & Amortization | 21.79 Million | 15.11 Million | 6.93 Million | 6.2 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 310 Thousand | 285 Thousand | - | - |
| Change in working capital | -21.66 Million | 1.56 Million | -219 Thousand | 4.96 Million |
| Other non-cash items | 27.83 Million | 11.34 Million | 180.52 Million | 45.59 Million |
| Investing Cash Flow | -99.64 Million | -55.47 Million | -21.25 Million | -13.76 Million |
| Investments in PPE | -30.93 Million | -21.79 Million | -19.58 Million | -13.76 Million |
| Acquisitions | -68.22 Million | -33.7 Million | - | - |
| Investment purchases | - | - | -1.66 Million | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -68.7 Million | -33.67 Million | -19.58 Million | -13.76 Million |
| Financing Cash Flow | 35.49 Million | 20.25 Million | -36.82 Million | -5.01 Million |
| Debt repayment | -59.68 Million | -36.85 Million | -58.78 Million | -5.55 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | 42.73 Million | - |
| Other Financing Activities | -20.31 Million | -13.83 Million | -13.41 Million | -9.33 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | -21.66 Million | 1.56 Million | -219 Thousand | 4.96 Million |
| Cash at beginning of period | 28.95 Million | 16.55 Million | 31.14 Million | 6.05 Million |
| Cash at end of period | 15.45 Million | 28.95 Million | 15.92 Million | 31.14 Million |
| Capital Expenditure | -30.93 Million | -21.79 Million | -19.58 Million | -13.76 Million |
| Effect of forex changes on cash | 192 Thousand | 138 Thousand | 211 Thousand | -260 Thousand |
| Net cash flow / Change in cash | -13.49 Million | 12.4 Million | -15.21 Million | 25.08 Million |
| Free Cash Flow | 19.52 Million | 25.68 Million | 23.06 Million | 30.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -630 Thousand | 1.45 Million | 18.4 Million | 8.71 Million | 4.15 Million | 11.21 Million |
| Depreciation & Amortization | 15.83 Million | 7.75 Million | 21.79 Million | - | 5.75 Million | 15.11 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 400 Thousand | 400 Thousand | 310 Thousand | - | 1.45 Million | 285 Thousand |
| Change in working capital | -5.83 Million | -3.85 Million | -21.66 Million | -9.76 Million | -6.6 Million | 1.56 Million |
| Other non-cash items | 21.08 Million | 14.15 Million | 27.83 Million | 3.64 Million | 3.2 Million | 11.34 Million |
| Investing Cash Flow | -8.96 Million | -9.6 Million | -99.64 Million | -16.07 Million | -11.4 Million | -55.47 Million |
| Investments in PPE | -9.12 Million | - | -30.93 Million | -8.82 Million | - | -21.79 Million |
| Acquisitions | -909 Thousand | - | -68.22 Million | -7.26 Million | - | -33.7 Million |
| Investment purchases | -25 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9.6 Million | -9.6 Million | -68.7 Million | - | -11.4 Million | -33.67 Million |
| Financing Cash Flow | 95.7 Million | 43.5 Million | 35.49 Million | -2.06 Million | -2.7 Million | 20.25 Million |
| Debt repayment | -57.61 Million | - | -59.68 Million | -5.44 Million | - | -36.85 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 172.19 Million | - | - | - | - | - |
| Other Financing Activities | -14.31 Million | 43.5 Million | -20.31 Million | -7.48 Million | -2.7 Million | -13.83 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.65 Million | -3.85 Million | -21.66 Million | - | -6.6 Million | 1.56 Million |
| Cash at beginning of period | 14.08 Million | - | 28.95 Million | 25.76 Million | - | 16.55 Million |
| Cash at end of period | 123.16 Million | 53.85 Million | 15.45 Million | 16.55 Million | -6.2 Million | 28.95 Million |
| Capital Expenditure | -9.12 Million | - | -30.93 Million | -8.82 Million | - | -21.79 Million |
| Effect of forex changes on cash | 28 Thousand | 50 Thousand | 192 Thousand | -28 Thousand | -50 Thousand | 138 Thousand |
| Net cash flow / Change in cash | 109.07 Million | 53.85 Million | -13.49 Million | -9.21 Million | -6.2 Million | 12.4 Million |
| Free Cash Flow | 13.18 Million | 19.9 Million | 19.52 Million | 115 Thousand | 7.95 Million | 25.68 Million |
VASUDHAGAM
0QP4
GWOX
300792
PLLSRMD00018
SHLTN